NovoCure Ltd financial data

Symbol
NVCR on Nasdaq
Location
St. Helier
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148% % -56%
Quick Ratio 5.1% % -61%
Debt-to-equity 261% % 16%
Return On Equity -50% % -21%
Return On Assets -14% % -9.4%
Operating Margin -28% % -0.04%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 111,981,981 shares 3.5%
Common Stock, Shares, Outstanding 111,979,981 shares 3.6%
Entity Public Float $860,375,045 USD -39%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 111,908,252 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 111,908,252 shares 3.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $642,269,000 USD 11%
Cost of Revenue $158,188,000 USD 16%
Research and Development Expense $214,849,000 USD 0.99%
Selling and Marketing Expense $238,815,000 USD 3.5%
General and Administrative Expense $207,128,000 USD 32%
Operating Income (Loss) $176,711,000 USD -11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $150,502,000 USD -31%
Income Tax Expense (Benefit) $27,148,000 USD -23%
Net Income (Loss) Attributable to Parent $177,650,000 USD -19%
Earnings Per Share, Basic -1 USD/shares -15%
Earnings Per Share, Diluted -1 USD/shares -15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $342,119,000 USD 85%
Accounts Receivable, after Allowance for Credit Loss, Current $85,230,000 USD 27%
Inventory, Net $39,104,000 USD 0.02%
Assets, Current $1,199,854,000 USD 9.5%
Property, Plant and Equipment, Net $79,976,000 USD 9.2%
Operating Lease, Right-of-Use Asset $48,402,000 USD 71%
Other Assets, Noncurrent $12,413,000 USD 1.5%
Assets $1,361,194,000 USD 11%
Employee-related Liabilities, Current $48,171,000 USD -5.6%
Contract with Customer, Liability, Current $15,700,000 USD 5.6%
Liabilities, Current $776,006,000 USD 5.6%
Operating Lease, Liability, Noncurrent $42,682,000 USD 102%
Other Liabilities, Noncurrent $19,000 USD 5.6%
Liabilities $1,019,861,000 USD 18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $5,806,000 USD -8%
Retained Earnings (Accumulated Deficit) $1,265,858,000 USD -16%
Stockholders' Equity Attributable to Parent $341,333,000 USD -5.4%
Liabilities and Equity $1,361,194,000 USD 11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $34,478,000 USD 8%
Net Cash Provided by (Used in) Financing Activities $110,836,000 USD 24%
Net Cash Provided by (Used in) Investing Activities $78,739,000 USD 601%
Common Stock, Shares, Issued 111,979,981 shares 3.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $155,439,000 USD 376%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $344,638,000 USD 82%
Interest Paid, Excluding Capitalized Interest, Operating Activities $10,942,000 USD 122%
Deferred Tax Assets, Valuation Allowance $1,636,833,000 USD 336%
Deferred Tax Assets, Gross $1,645,883,000 USD 326%
Operating Lease, Liability $27,880,000 USD -22%
Payments to Acquire Property, Plant, and Equipment $30,694,000 USD -25%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $178,078,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid $32,688,000 USD -23%
Property, Plant and Equipment, Gross $109,970,000 USD 38%
Operating Lease, Liability, Current $7,909,000 USD -3.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,814,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,369,000 USD -4.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,808,000 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,249,000 USD -20%
Deferred Tax Assets, Operating Loss Carryforwards $127,881,000 USD 28%
Unrecognized Tax Benefits $18,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,874,000 USD -27%
Additional Paid in Capital $1,612,997,000 USD 11%
Deferred Tax Assets, Net of Valuation Allowance $9,050,000 USD -16%
Share-based Payment Arrangement, Expense $147,773,000 USD 29%